Valuation: CVRx, Inc.

Market Cap 6.9Cr 6.07Cr 5.74Cr 5.21Cr 9.78Cr 662.36Cr 9.83Cr 69Cr 27Cr 337.99Cr 26Cr 25Cr 1.09TCr P/E 2026 *
-1.29x
P/E 2027 * -1.35x
Enterprise Value 7.95Cr 6.99Cr 6.61Cr 6Cr 11Cr 763.18Cr 11Cr 79Cr 31Cr 389.43Cr 30Cr 29Cr 1.25TCr EV / Sales 2026 *
1.35x
EV / Sales 2027 * 1.69x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day-4.07%
1 week-12.79%
Current month-12.50%
1 month-12.20%
3 months-55.80%
6 months-70.93%
Current year-63.52%
1 week 2.51
Extreme 2.51
2.89
1 month 2.51
Extreme 2.51
3.18
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26 Buy

Chief Operating Officer

26,223 0.0988%
12/08/26 Sell

Chief Operating Officer

-1,309 0.0049%
01/06/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-4.07%-12.79%-65.70%-82.94% 6.9Cr
+0.09%+0.13%+25.97%+29.33% 1.26TCr
+3.33%+4.24%+24.57%+31.41% 686.54Cr
+1.53%-0.66%+40.75%+23.36% 550.36Cr
+2.55%-2.98% - - 576.49Cr
+2.47%-0.66%-23.55%+32.84% 501.59Cr
-0.19%-0.15%-31.20%-23.55% 390.64Cr
-0.06%-4.23%+22.81%-4.81% 184.33Cr
+2.71%+5.39%-7.62%+185.18% 172.46Cr
-2.27%-4.38%+44.49%-16.28% 155.61Cr
Average +0.61%-1.21%+3.39%+19.39% 448.22Cr
Weighted average by Cap. +1.33%+0.17%+14.67%+27.27%

Financials

2026 *2027 *
Net sales 5.89Cr 5.18Cr 4.89Cr 4.44Cr 8.34Cr 564.94Cr 8.39Cr 59Cr 23Cr 288.28Cr 22Cr 22Cr 926.37Cr 6.62Cr 5.82Cr 5.5Cr 4.99Cr 9.38Cr 635.27Cr 9.43Cr 66Cr 25Cr 324.17Cr 25Cr 24Cr 1.04TCr
Net income -5.35Cr -4.7Cr -4.45Cr -4.03Cr -7.57Cr -513.09Cr -7.62Cr -53Cr -21Cr -261.82Cr -20Cr -20Cr -841.35Cr -5.21Cr -4.59Cr -4.34Cr -3.93Cr -7.39Cr -500.46Cr -7.43Cr -52Cr -20Cr -255.37Cr -20Cr -19Cr -820.63Cr
Net Debt 1.05Cr 92.38L 87.35L 79.23L 1.49Cr 100.82Cr 1.5Cr 10Cr 4.04Cr 51Cr 3.94Cr 3.86Cr 165.32Cr 4.29Cr 3.78Cr 3.57Cr 3.24Cr 6.08Cr 412.17Cr 6.12Cr 43Cr 17Cr 210.32Cr 16Cr 16Cr 675.86Cr
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
28/26/28 $2.590 -4.07% 3,81,980
25/26/25 $2.700 +6.72% 4,62,364
24/26/24 $2.530 -6.99% 6,93,693
23/26/23 $2.720 -5.88% 4,82,039
22/26/22 $2.890 -2.69% 6,66,182
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.590USD
Average target price
4.583USD
Spread / Average Target
+76.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock